Interleukin-2 rescues helpless effector CD8+ T cells by diminishing the susceptibility to TRAIL mediated death
- 30 September 2011
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 139 (1-2), 25-32
- https://doi.org/10.1016/j.imlet.2011.04.011
Abstract
No abstract availableKeywords
Funding Information
- Career Development Award from the Leukemia and Lymphoma Society
- National Institutes of Health
- Cancer Research Institute/Irvington Institute
This publication has 31 references indexed in Scilit:
- Critical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responsesEuropean Journal of Immunology, 2010
- γ c deficiency precludes CD8 + T cell memory despite formation of potent T cell effectorsProceedings of the National Academy of Sciences of the United States of America, 2010
- CD4 + T cell regulation of CD25 expression controls development of short-lived effector CD8 + T cells in primary and secondary responsesProceedings of the National Academy of Sciences, 2009
- Different T Cell Receptor Signals Determine CD8 + Memory Versus Effector DevelopmentScience, 2009
- IL-15 as a mediator of CD4 + help for CD8 + T cell longevity and avoidance of TRAIL-mediated apoptosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune diseaseExpert Opinion on Biological Therapy, 2006
- Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cellsNature, 2006
- Induction of Tumor-specific T Cell Immunity by Anti-DR5 Antibody TherapyThe Journal of Experimental Medicine, 2004
- Bcl-2 over-expression and activation of protein kinase C suppress the Trail-induced apoptosis in Jurkat T cellsCell Research, 2001
- T CELL MEMORYAnnual Review of Immunology, 1998